New Jersey Center for Cancer Research — Brick, New Jersey

New Jersey Center for Cancer Research is a clinical research site located in Brick, New Jersey, United States 08724.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

New Jersey Center for Cancer Research has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: SARS-CoV-2 Infection, Acute Myeloid Leukemia, B-cell Non-Hodgkin Lymphoma.

Sponsors: MediMergent, LLC, Prelude Therapeutics, Loxo Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Center for Cancer Research?

New Jersey Center for Cancer Research has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Center for Cancer Research conducted?

New Jersey Center for Cancer Research has 8 clinical trials on record, with 2 currently active. Their work covers SARS-CoV-2 Infection, Acute Myeloid Leukemia, B-cell Non-Hodgkin Lymphoma.

Is New Jersey Center for Cancer Research accredited by Crixeo Health?

Yes — New Jersey Center for Cancer Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New Jersey Center for Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.